Home
Conditions
Burkitt Lymphoma

Clinical trial condition

Burkitt Lymphoma

Explore clinical trials studying Burkitt Lymphoma. Study availability and eligibility vary by location and protocol.

695 public trials 115 recruiting studies

Refine in advanced search Browse all conditions

Burkitt Lymphoma trial results

Completed

Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma

NCT00006102

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +55 more
Locations: University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States

University of South Alabama Medical Center Mobile, Alabama, United States

Phoenix Children's Hospital Phoenix, Arizona, United States

Arizona Cancer Center Tucson, Arizona, United States

View all 226 locations

View Trial Details

Completed

Bryostatin-1 in Treating Patients With Recurrent Non-Hodgkin's Lymphoma

NCT00002725

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +29 more
Locations: University of Texas - MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or Lymphoma

NCT00002759

Conditions: Agranulocytosis, Burkitt Lymphoma, Chemically-Induced Disorders, +51 more
Locations: University of Chicago Cancer Research Center Chicago, Illinois, United States

View Trial Details

Completed

Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer

NCT00003451

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +84 more
Locations: Arthur G. James Cancer Hospital - Ohio State University Columbus, Ohio, United States

View Trial Details

Completed

S0108 Bevacizumab in Treating Patients With Non-Hodgkin's Lymphoma

NCT00016094

Conditions: Anaplastic Large Cell Lymphoma, Burkitt Lymphoma, DNA Virus Infections, +22 more
Locations: Southwest Oncology Group San Antonio, Texas, United States

View Trial Details

Completed

Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Post-Transplant Lymphoproliferative Disorder

NCT00064246

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +32 more
Locations: AIDS - Associated Malignancies Clinical Trials Consortium Rockville, Maryland, United States

View Trial Details

Completed

17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphomas

NCT00089271

Conditions: Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Blood Protein Disorders, +97 more
Locations: University of Pittsburgh Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

MS-275 and Isotretinoin in Treating Patients With Metastatic or Advanced Solid Tumors or Lymphomas

NCT00098891

Conditions: Adult Grade III Lymphomatoid Granulomatosis, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +92 more
Locations: Johns Hopkins University Baltimore, Maryland, United States

View Trial Details

Completed

Genetic Testing Plus Irinotecan in Treating Patients With Solid Tumors or Lymphoma

NCT00003970

Conditions: AIDS-related Peripheral/Systemic Lymphoma, AIDS-related Primary CNS Lymphoma, Anaplastic Large Cell Lymphoma, +99 more
Locations: University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States

View Trial Details

Completed

Cilengitide (EMD 121974) in Treating Patients With Advanced Solid Tumors or Lymphoma

NCT00077155

Conditions: AIDS-related Peripheral/Systemic Lymphoma, AIDS-related Primary CNS Lymphoma, Anaplastic Large Cell Lymphoma, +95 more
Locations: University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States

View Trial Details

Burkitt Lymphoma

Burkitt Lymphoma trial results

Related conditions